ABSTRACT
Crohn's disease (CD) is a chronic inflammatory condition of the gastrointestinal tract. Individuals with CD present with acute inflammatory exacerbations as well as acute and chronic complications. Management requires specialist input from gastroenterologists, colorectal surgeons, nurse specialists and pharmacists as well as general and primary care physicians to allow appropriate selection of treatment options including surgery and rapid assessment and treatment of those with acute exacerbations. Monitoring of the individual and their medication is crucial in preventing and recognising complications including those associated with treatment. This concise guideline focuses on recommendations from National Institute for Health and Care Excellence (NICE) -Clinical -Guideline 152 (CG152) considered of key importance for implementation.
Subject(s)
Crohn Disease/therapy , Gastrointestinal Agents/therapeutic use , Glucocorticoids/therapeutic use , Immunosuppressive Agents/therapeutic use , Patient Education as Topic , Adalimumab/therapeutic use , Adolescent , Adult , Bone Diseases, Metabolic/chemically induced , Bone Diseases, Metabolic/diagnosis , Bone Diseases, Metabolic/therapy , Child , Digestive System Surgical Procedures , Disease Management , Humans , Infliximab/therapeutic use , Maintenance Chemotherapy , Osteoporotic Fractures/epidemiology , Osteoporotic Fractures/prevention & control , Practice Guidelines as Topic , Remission Induction , Young AdultABSTRACT
Ulcerative colitis is a chronic, relapsing and remitting -inflammatory disease of the colon and rectum. Effective -management requires prompt recognition and treatment of those with acute relapses as well as appropriate choice and monitoring of drugs for maintenance of remission. This therefore involves specialist gastroenterology teams as well as acute and general physicians and primary care clinicians. Treatment options need to be discussed with those with -ulcerative colitis and their families and appropriate information provided. This concise guideline focuses (with the generalist particularly in mind) on recommendations from the National Institute for Health and Care Excellence clinical guideline 166 considered of key importance for implementation.
